Thromboxane A(2) synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding

European Journal of Pharmacology
K I KawanoK Umemura

Abstract

The advantage of platelet integrin GPIIb-IIIa receptor antagonists in the prevention of thrombotic occlusion was clearly proven in patients who underwent interventional treatment of the coronary artery, but its value in cerebral ischemia is still under investigation. The expectation of intracranial hemorrhage on strong inhibition of platelet function restricts its application in cerebral ischemia. To minimize bleeding while keeping antithrombotic activity, we have tried to find an appropriate approach using a combination of platelet integrin GPIIb-IIIa receptor antagonist and some other antithrombotic agents. The time to thrombotic occlusion was measured using a photothrombotic occlusion model of guinea pig middle cerebral artery. A platelet integrin GPIIb-IIIa receptor antagonist, ME3277 (sodium hydrogen [4-[(4,5,6,7-tetrahydrothieno [3,2-c] pyridin-2-yl) carbonylamino] acetyl-o-phenylene] dioxydiacetate), delayed occlusion time from 7.3 min in vehicle to 15.0, 20.6 and 25.9 min (P<0.05) at 0.1, 0.3 and 1 mg/kg, respectively. ME3277 profoundly inhibited ex vivo platelet aggregation and the highest dose of ME3277 prolonged (3.5 folds, P<0.01) the bleeding time measured in the hind paw. A thromboxane A(2) synthase inhibitor, sod...Continue Reading

References

Jul 1, 1977·Stroke; a Journal of Cerebral Circulation·E F EllisJ A Oates
Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·M HambergB Samuelsson
May 3, 1991·Cell·D R PhillipsR M Scarborough
May 1, 1990·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·T K Uski, P Reinstrup
May 1, 1985·Annals of Neurology·B D WatsonM D Ginsberg
Sep 1, 1984·The Journal of Clinical Investigation·M D McGoon, P M Vanhoutte
Jan 1, 1995·Clinical and Experimental Hypertension : CHE·J L ReidI M Macrae
Dec 15, 1994·Thrombosis Research·J D MacDonaldG M Rodgers
Mar 4, 2000·Stroke; a Journal of Cerebral Circulation·UNKNOWN Abciximab in Ischemic Stroke Investigators

❮ Previous
Next ❯

Citations

Nov 15, 2002·Brain Research. Brain Research Protocols·Yasuhiro SuzukiKazuo Umemura
Apr 21, 2004·Coronary Artery Disease·David J SchneiderBurton E Sobel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.